The spread has widened to 8% due to regulatory approval concerns. Regulatory approval should be forthcoming as the transaction involves Chinese entities acquiring a Chinese-focused company.
What is covered in the Full Insight:
Transaction Delay Explanation
Closing Conditions Status
Chinese Regulatory Approvals Introduction
NDRC, MOFCOM and SAFE Procedures
Reasons why regulatory approvals should be forthcoming
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.